Product News
Rivaroxaban demonstrates strong efficacy and safety profile in phase III study in children with thromboembolism
Results from the phase III EINSTEIN-Jr. study showed a strong efficacy and safety profile of rivaroxaban in children with VTE, with results similar to those seen in previous…